Key Takeaways: The table displays the top 100 most frequently reported adverse events associated with Aspirin in the FAERS database. The most common side effects include conditions such as gastrointestinal bleeding, nausea, and dizziness, which are well-documented risks of Aspirin use. This visualization allows users to quickly identify potential safety concerns and assess the relative frequency of different adverse reactions, which is valuable for pharmacovigilance and post-market drug safety monitoring.
Key Takeaways: This chart illustrates the proportions of serious outcomes (e.g., hospitalization, life-threatening events, death) linked to Aspirin-related adverse events. A significant number of reports involve hospitalization, indicating that some adverse effects may require medical intervention. By allowing users to toggle specific outcomes, this visualization helps in understanding the severity of reported cases, aiding healthcare professionals and regulatory agencies in monitoring drug safety trends.
The dataset used in this dashboard is the FDA Adverse Event Reporting
System (FAERS), a public database managed by the U.S. FDA.
It includes voluntary reports of adverse drug events from healthcare
providers, manufacturers, and consumers.
This dashboard uses data from Q1 2023 to Q4 2024, extracted from ASCII
files provided by the FDA.
Reports were filtered for those involving “ASPIRIN” as the suspect
drug.
All adverse events are coded using standardized MedDRA terms.
This dashboard helps healthcare professionals, patients, and
regulators assess the post-market safety of Aspirin.
It supports evidence-based decision-making by visualizing real-world
adverse event reports.